Point-of-care measurements of HbA1c: Simplicity does not mean laxity with controls

Diabetes Care

Volumn 35, Issue 12, 2012, Pages

  Leca, Viviane ^a   Ibrahim, Zouher ^a   Lombard Pontou, Elise ^a   Maraninchi, Marie ^a,b   Guieu, Régis ^a   Portugal, Henri ^a,b   Valéro, René ^a,b   Vialettes, Bernard ^a  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CAPILLARY; CONTROLLED STUDY; DECISION MAKING; DIABETES CONTROL; DIABETES MELLITUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; QUALITY CONTROL; RELIABILITY;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 84869804189     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0751     Document Type: Article

References (5)

1. Al-Ansary L, Farmer A, Hirst J, et al. Point-of-care testing for HbA1c in the management of diabetes: a systematic review and meta-analysis. Clin Chem 2011;57:568-576
2. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010;56:44-52
3. Holmes EW, Ersxahin C, Augustine GJ, et al. Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern? Am J Clin Pathol 2008;129:540-547 (Pubitemid 352029272)
4. Twomey PJ, Rayman G, Pledger DR. Implications of different DCCT-aligned HbA1c methods on GMS clinical indicators. Diabet Med 2008;25:97-100
5. Little RR, Lenters-Westra E, Rohlfing CL, Slingerland R. Point-of-care assays for hemoglobin A(1c): is performance adequate? Clin Chem 2011;57:1333-1334